Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon

Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon

Abstract The idiopathic inflammatory myopathies (IIM) until recently have been considered a heterogeneous broad group of six autoimmune muscle diseases. Initially, autoantibodies in IIM (including JDM) and CD8+ T cell-induced cytotoxicity (PM and IBM) were the predominant recognized etiopathology me...

Full description

Bibliographic Details
Main Authors: Anjali Patwardhan, Charles H. Spencer
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Idiopathic inflammatory myopathies
Dermatomyositis
Polymyositis
Juvenile dermatomyositis
Interferon
Cytokines
Online Access:http://link.springer.com/article/10.1186/s12969-019-0361-2

Internet

http://link.springer.com/article/10.1186/s12969-019-0361-2

Similar Items